Table 3.
The Childhood Cancer Risk among Offspring of Mothers with Hypertension before Birth, Stratifying by Medication Use
| Hypertension before birth (all types) | ||||
|---|---|---|---|---|
| Cases (n=2,780) | Non-cases (n=2,291,512) | Crude HR (95% CI) | *Adjusted HR (95% CI) | |
| No diagnosis of hypertension before birth | 2,664 | 2,194,495 | 1 (ref) | 1 (ref) |
| Maternal hypertension before birth | 92 | 72,656 | 1.14 (0.93–1.40) | 1.12 (0.90–1.41) |
| No medications before birth | 12 | 11,403 | 0.94 (0.53–1.65) | 0.98 (0.56–1.73) |
| Any medications before birth other than diuretics | 54 | 40,583 | 1.20 (0.92–1.57) | 1.15 (0.86–1.54) |
| Diuretics before birth | 26 | 20,670 | 1.13 (0.77–1.66) | 1.16 (0.77–1.74) |
| Hypertension and diuretic use between conception (0 weeks) and birth | 10 | 8,945 | 0.98 (0.53–1.83) | 0.94 (0.48–1.83) |
| Hypertension but without diuretic use between conception (0 weeks) and birth | 80 | 63,350 | 1.13 (0.91–1.42) | 1.13 (0.89–1.43) |
Model adjusted for parity, preeclampsia/eclampsia in the index pregnancy, family income, infections in pregnancy, and hyperthyroidism